Graham Capital Management’s Teladoc Health TDOC Stock Holding History

Graham Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-51,313	Closed	-$359K	–	1500
2025 Q4	$359K	Buy	+51,313	New	+$402K	0.01%	769
2025 Q1	–	Sell	-20,174	Closed	-$183K	–	1514
2024 Q4	$183K	Buy	+20,174	New	+$195K	﹤0.01%	1093
2024 Q2	–	Sell	-92,000	Closed	-$1.39M	–	1357
2024 Q1	$1.39M	Buy	92,000 +55,013	+149%	+$998K	0.03%	327
2023 Q4	$797K	Buy	36,987 +22,437	+154%	+$414K	0.02%	448
2023 Q3	$270K	Sell	14,550 -113,850	-89%	-$2.66M	0.01%	758
2023 Q2	$3.25M	Buy	128,400 +103,399	+414%	+$2.6M	0.09%	146
2023 Q1	$648K	Sell	25,001 -68,497	-73%	-$1.83M	0.02%	665
2022 Q4	$2.21M	Buy	+93,498	New	+$2.52M	0.07%	235

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's TDOC Position: Q1 2026 in Review

Graham Capital Management sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 51,313 shares — an estimated $359K sold.

Graham Capital Management first reported a position in TDOC in Q4 2022 and held it in 8 quarters. The position peaked at $3.25M in Q2 2023. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Graham Capital Management reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
Graham Capital Management sold 51,313 Teladoc Health shares in Q1 2026, an estimated $359K.
Graham Capital Management first reported a position in Teladoc Health in Q4 2022 and held it in 8 quarters.
Graham Capital Management's Teladoc Health position peaked at $3.25M in Q2 2023.
325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.